Effects of Bariatric Surgery on Pelvic Floor Fonctions in Obese Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Urinary incontinence is well documented as a comorbidity of obesity. Studies demonstrate improvement of incontinency after weight loss. However, the mechanisms are still not clear. Aim of our study to analyze the effects of bariatric surgery on pelvic floor function in women.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long Term Effect of Bariatric Surgery on Pelvic Floor Disorders

NCT04575987

Bariatric Surgery Candidate Weight Loss

UNKNOWN

Vestibular Function in Obesity

NCT07033221

Obesity Vestibular Function Disorder Balance Assessment +2 more

RECRUITING

Online Clinic Pilates Exercises in Patients Undergoing Bariatric Surgery

NCT05454696

Bariatric Surgery Obesity Exercise +1 more

COMPLETED NA

Impact of Bariatric Surgery in Patients With Morbid Obesity

NCT04009356

Obesity, Morbid Anal Incontinence Image, Body

COMPLETED

Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet

NCT04159467

Urinary Incontinence Obesity Strength; Pelvic Floor

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity is considered an important public health problem, both in developed and developing countries. Obese people are at a higher risk for developing various comorbidities: type II diabetes, dyslipidemia, cardiovascular and cerebrovascular diseases, coagulation disorders, degenerative joint disease, some types of cancer, sleep apnea and urinary incontinence Women suffering from obesity are more likely to develop urinary incontinence, especially when related to stress. Excess weight is a modifiable risk factor. It is believed that weight reduction may be an effective treatment for urinary incontinence. The aim of this study is to analyze the effects of weight loss induced by bariatric surgery on pelvic floor function. Taking into account that modest weight loss (5% to 10%) already brings benefits to women with obesity and incontinence, one may assume even more marked improvement owing to the massive loss of weight by surgical means.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Incontinence Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

obese women who underwent bariatric surgery

bariatric surgery

Intervention Type PROCEDURE

bariatric surgery for obese women

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bariatric surgery

bariatric surgery for obese women

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body mass index ≥ 40 kg/m2
* \>18 years old
* participants who provided written informed consent

Exclusion Criteria

* History of gynecologic operation time under one year
* History of pelvic physiotherapy
* Chronic obstructif lung disease
* Norologic disease
* Women in menopause

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No